Co-Authors
This is a "connection" page, showing publications co-authored by SCOTT B CANTOR and YA-CHEN TINA SHIH.
Connection Strength
0.565
-
Impact of generic drug entry on cost-effectiveness analysis. Med Decis Making. 2005 Jan-Feb; 25(1):71-80.
Score: 0.262
-
Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy. JCO Clin Cancer Inform. 2019 03; 3:1-12.
Score: 0.175
-
The association between symptom burdens and utility in Chinese cancer patients. Qual Life Res. 2006 Oct; 15(8):1427-38.
Score: 0.073
-
In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: clinical and economic outcomes from the Nationwide Inpatient Sample. Cancer. 2008 Mar 01; 112(5):1096-105.
Score: 0.020
-
Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results. Biol Blood Marrow Transplant. 2007 Jul; 13(7):806-13.
Score: 0.019
-
Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis. Support Care Cancer. 2004 Jul; 12(7):531-6.
Score: 0.015